Reuters logo
4 years ago
Allergan misses in quarter, but 2013 view tops forecasts
February 5, 2013 / 2:10 PM / 4 years ago

Allergan misses in quarter, but 2013 view tops forecasts

1 Min Read

Feb 5 (Reuters) - Allergan Inc, maker of the Botox anti-wrinkle treatment, reported quarterly earnings below Wall Street forecasts, but projected better-than expected earnings for full-year 2013.

The company on Tuesday said it earned $324 million, or $1.06 per share, in the fourth quarter. That compared with $280 million, or 90 cents per share, in the year-earlier period.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below